In Vitro Perspective on Hypofractionated Radiotherapy in Breast Cancer
Open Access
Abstract
Breast cancer remains a major global health challenge, with treatment access further constrained during the COVID-19 pandemic, particularly in resource-limited settings. This study evaluates the in vitro effects of hypofractionated versus conventionally fractionated radiotherapy on three breast cell lines: MCF-7 (oestrogen receptor-positive, ER+/PR+), MDA-MB-231 (triple-negative: ER−/PR−/HER2−), and MCF-10A (non-tumorigenic mammary epithelial). Cells were exposed to cobalt-60 γ-rays, and radiobiological endpoints assessed included clonogenic survival, α/β ratios, adaptive responses, migration, invasion, and cytotoxicity through lactate dehydrogenase assays. The α/β ratios ranged from 2.5 to 5.4 Gy across breast cancer subtypes. Hypofractionation reduced survival in hormone receptor-positive cells, whereas triple-negative cells exhibited increased survival. Adaptive radiation responses enhanced viability across all cell lines, while non-cancerous MCF-10A cells demonstrated reduced migration following treatment. These findings suggest that hypofractionated radiotherapy may be beneficial in hormone receptor-positive breast cancer, while triple-negative disease may show a trend toward different responses, although this was not statistically significant (MDA-MB-231, p = 0.290). The results underscore the importance of tailoring fractionation strategies to breast cancer subtype and highlight the translational potential of preclinical radiobiology in guiding personalised radiation oncology approaches.Keywords
All Related Versions
Funding Information
- Southern African Institute for Nuclear Technology and Sciences (SAINTS), iThemba LABS (iLABS4200257)
This publication has 54 references indexed in Scilit:
- Hypofractionation: The standard for external beam breast irradiationThe Breast, 2023
- Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central MassachusettsCancer Causes & Control, 2022
- Patient-reported treatment delays in breast cancer care during the COVID-19 pandemicBreast Cancer Research and Treatment, 2020
- Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization RecommendationsAdvances in Radiation Oncology, 2020
- In vitro assays and techniques utilized in anticancer drug discoveryJournal of Applied Toxicology, 2018
- Metabolic targets of watercress and PEITC in MCF-7 and MCF-10A cells explain differential sensitisation responses to ionising radiationEuropean Journal of Nutrition, 2018
- Molecular Heterogeneity of Triple-Negative Breast CancerCurrent Breast Cancer Reports, 2014
- Radiation Biology of Radiation Protection2014
- Thirteen new p53 gene mutants identified among 41 human breast cancer cell linesBreast Cancer Research and Treatment, 2006
- A review of ratios for experimental tumors: Implications for clinical studies of altered fractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985